Title:
NEW APPLICATION FOR LONG-ACTING MUTANT HUMAN FIBROBLAST GROWTH FACTOR
Document Type and Number:
WIPO Patent Application WO/2018/171557
Kind Code:
A1
Abstract:
Disclosed in the present invention is a new application for a long-acting mutant human fibroblast growth factor, the long-acting mutant human fibroblast growth factor being PEGylation Recombinant Human-mouse Chimeric Fibroblast Growth Factor 21, and the new application being the preparation of a drug for the treatment of non-alcoholic steatohepatitis.
Inventors:
LI JIAN (CN)
HAN JUN (CN)
MA XIAOHUI (CN)
TAI PING (CN)
WANG GENBEI (CN)
CAO XIAODAN (CN)
HUANG RUIJING (CN)
JIN YONGJIE (CN)
LI JING (CN)
CHEN CHEN (CN)
JIA GUOYONG (CN)
WANG YUANYUAN (CN)
HAN JUN (CN)
MA XIAOHUI (CN)
TAI PING (CN)
WANG GENBEI (CN)
CAO XIAODAN (CN)
HUANG RUIJING (CN)
JIN YONGJIE (CN)
LI JING (CN)
CHEN CHEN (CN)
JIA GUOYONG (CN)
WANG YUANYUAN (CN)
Application Number:
PCT/CN2018/079482
Publication Date:
September 27, 2018
Filing Date:
March 19, 2018
Export Citation:
Assignee:
TASLY PHARMACEUTICAL GROUP CO (CN)
International Classes:
A61K38/18; A61P1/16
Foreign References:
| CN103124562A | 2013-05-29 | |||
| CN103193878A | 2013-07-10 | |||
| CN105792851A | 2016-07-20 | |||
| CN201310115210A | 2013-04-03 | |||
| CN103193878A | 2013-07-10 |
Other References:
See also references of EP 3603660A4
LIU MIN ET AL.: "Effect of fibroblast growth factor-21 on lipid metabolism of non-alcoholic fatty liver cell model induced in vitro", JOURNAL OF JILIN UNIVERSITY, vol. 38, no. 3, May 2012 (2012-05-01), pages 477 - 481
LIU MIN ET AL.: "Effect of fibroblast growth factor-21 on lipid metabolism of non-alcoholic fatty liver cell model induced in vitro", JOURNAL OF JILIN UNIVERSITY, vol. 38, no. 3, May 2012 (2012-05-01), pages 477 - 481
Attorney, Agent or Firm:
BEIJING JOYSHINE INTELLECTUAL PROPERTY OFFICE (CN)
Download PDF: